Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

A controlled trial of mobile short message service among participants in a rural cardiovascular disease prevention program.

Gore MO, Krantz MJ, Albright K, Beaty B, Coronel-Mockler S, Bull S, Estacio RO.

Prev Med Rep. 2018 Nov 30;13:126-131. doi: 10.1016/j.pmedr.2018.11.021. eCollection 2019 Mar.

2.

Reduction in Cardiovascular Risk Among Latino Participants in a Community-Based Intervention Linked With Clinical Care.

Krantz MJ, Beaty B, Coronel-Mockler S, Leeman-Castillo B, Fletcher K, Estacio RO.

Am J Prev Med. 2017 Aug;53(2):e71-e75. doi: 10.1016/j.amepre.2017.04.012. Epub 2017 Jun 8.

PMID:
28602543
3.

Is 60 the New 80 in Hypertension?

Pflederer MC, Estacio RO, Krantz MJ.

J Gen Intern Med. 2016 Aug;31(8):958-60. doi: 10.1007/s11606-016-3649-7. Epub 2016 Mar 28. Review.

4.

Augmenting Predictive Modeling Tools with Clinical Insights for Care Coordination Program Design and Implementation.

Johnson TL, Brewer D, Estacio R, Vlasimsky T, Durfee MJ, Thompson KR, Everhart RM, Rinehart DJ, Batal H.

EGEMS (Wash DC). 2015 Jul 30;3(1):1181. doi: 10.13063/2327-9214.1181. eCollection 2015.

5.

Health Promotion Text Messaging Preferences and Acceptability Among the Medically Underserved.

Albright K, Krantz MJ, Backlund Jarquín P, DeAlleaume L, Coronel-Mockler S, Estacio RO.

Health Promot Pract. 2015 Jul;16(4):523-32. doi: 10.1177/1524839914566850. Epub 2015 Jan 13.

PMID:
25586133
6.

Effectiveness of a community health worker cardiovascular risk reduction program in public health and health care settings.

Krantz MJ, Coronel SM, Whitley EM, Dale R, Yost J, Estacio RO.

Am J Public Health. 2013 Jan;103(1):e19-27. doi: 10.2105/AJPH.2012.301068. Epub 2012 Nov 15.

7.

Relation of reduction in urinary albumin excretion to ten-year cardiovascular mortality in patients with type 2 diabetes and systemic hypertension.

Estacio RO, Dale RA, Schrier R, Krantz MJ.

Am J Cardiol. 2012 Jun 15;109(12):1743-8. doi: 10.1016/j.amjcard.2012.02.020. Epub 2012 Mar 20.

PMID:
22440125
8.

Care by cell phone: text messaging for chronic disease management.

Fischer HH, Moore SL, Ginosar D, Davidson AJ, Rice-Peterson CM, Durfee MJ, MacKenzie TD, Estacio RO, Steele AW.

Am J Manag Care. 2012 Feb 1;18(2):e42-7.

9.

Nurse-run, telephone-based outreach to improve lipids in people with diabetes.

Fischer HH, Eisert SL, Everhart RM, Durfee MJ, Moore SL, Soria S, Stell DI, Rice-Peterson C, MacKenzie TD, Estacio RO.

Am J Manag Care. 2012 Feb;18(2):77-84.

10.

Assessment of bacterial diversity in selected Philippine fermented food products through PCR-DGGE.

Dalmacio LM, Angeles AK, Larcia LL, Balolong MP, Estacio RC.

Benef Microbes. 2011 Dec 1;2(4):273-81. doi: 10.3920/BM2011.0017.

PMID:
22146687
11.

Bacterial diversity in Philippine fermented mustard (burong mustasa) as revealed by 16S rRNA gene analysis.

Larcia LL 2nd, Estacio RC, Dalmacio LM.

Benef Microbes. 2011 Dec 1;2(4):263-71. doi: 10.3920/BM2011.0019.

PMID:
22146686
12.

Reducing cardiovascular disease risk using patient navigators, Denver, Colorado, 2007-2009.

Shlay JC, Barber B, Mickiewicz T, Maravi M, Drisko J, Estacio R, Gutierrez G, Urbina C.

Prev Chronic Dis. 2011 Nov;8(6):A143. Epub 2011 Oct 17.

13.

Impact of cardiovascular disease guideline dissemination on provider knowledge.

Heppe DB, Bucher-Bartelson B, Estacio RO, Krantz MJ.

Am J Med Sci. 2012 Jan;343(1):56-60. doi: 10.1097/MAJ.0b013e31822817e6.

PMID:
21817880
14.

Pulse wave velocity and carotid atherosclerosis in white and Latino patients with hypertension.

Krantz MJ, Long CS, Hosokawa P, Karimkahani E, Dickinson M, Estacio RO, Masoudi FA, Havranek EP.

BMC Cardiovasc Disord. 2011 Apr 11;11:15. doi: 10.1186/1471-2261-11-15.

15.

Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors.

Hurley LP, Dickinson LM, Estacio RO, Steiner JF, Havranek EP.

Circ Cardiovasc Qual Outcomes. 2010 Mar;3(2):181-7. doi: 10.1161/CIRCOUTCOMES.108.831073. Epub 2010 Feb 2.

16.

Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension.

Steiner JF, Ho PM, Beaty BL, Dickinson LM, Hanratty R, Zeng C, Tavel HM, Havranek EP, Davidson AJ, Magid DJ, Estacio RO.

Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):451-7. doi: 10.1161/CIRCOUTCOMES.108.841635. Epub 2009 Aug 11.

17.

Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension.

Hanratty R, Chonchol M, Miriam Dickinson L, Beaty BL, Estacio RO, Mackenzie TD, Hurley LP, Linas SL, Steiner JF, Havranek EP.

Nephrol Dial Transplant. 2010 Mar;25(3):801-7. doi: 10.1093/ndt/gfp534. Epub 2009 Nov 4.

18.

Injury and death associated with incidents reported to the patient safety net.

Reid M, Estacio R, Albert R.

Am J Med Qual. 2009 Nov-Dec;24(6):520-4. doi: 10.1177/1062860609345788. Epub 2009 Sep 4.

PMID:
19734322
19.

Renin-angiotensin-aldosterone system blockade in diabetes: role of direct renin inhibitors.

Estacio RO.

Postgrad Med. 2009 May;121(3):33-44. doi: 10.3810/pgm.2009.05.2000. Review.

PMID:
19491538
20.

Serum phosphorus and cardiovascular mortality in type 2 diabetes.

Chonchol M, Dale R, Schrier RW, Estacio R.

Am J Med. 2009 Apr;122(4):380-6. doi: 10.1016/j.amjmed.2008.09.039.

PMID:
19332233
21.

Design of a nurse-run, telephone-based intervention to improve lipids in diabetics.

Fischer H, Mackenzie T, McCullen K, Everhart R, Estacio RO.

Contemp Clin Trials. 2008 Sep;29(5):809-16. doi: 10.1016/j.cct.2008.05.011. Epub 2008 Jun 11.

PMID:
18606250
22.

Testing electronic algorithms to create disease registries in a safety net system.

Hanratty R, Estacio RO, Dickinson LM, Chandramouli V, Steiner JF, Havranek EP; Latino Using Cardio Health Actions to Reduce Risk study investigators.

J Health Care Poor Underserved. 2008 May;19(2):452-65. doi: 10.1353/hpu.0.0027.

23.

Thresholds in the relationship between mortality and left ventricular hypertrophy defined by electrocardiography.

Havranek EP, Emsermann CD, Froshaug DN, Masoudi FA, Krantz MJ, Hanratty R, Estacio RO, Dickinson LM, Steiner JF.

J Electrocardiol. 2008 Jul-Aug;41(4):342-50. doi: 10.1016/j.jelectrocard.2007.11.006. Epub 2008 Mar 14.

24.

Heart rate recovery predicts mortality and cardiovascular events in patients with type 2 diabetes.

Chacko KM, Bauer TA, Dale RA, Dixon JA, Schrier RW, Estacio RO.

Med Sci Sports Exerc. 2008 Feb;40(2):288-95. doi: 10.1249/mss.0b013e31815c4844.

PMID:
18202573
25.

Relationship between urinary albumin excretion and left ventricular mass with mortality in patients with type 2 diabetes.

Nobakhthaghighi N, Kamgar M, Bekheirnia MR, McFann K, Estacio R, Schrier RW.

Clin J Am Soc Nephrol. 2006 Nov;1(6):1187-90. Epub 2006 Sep 13.

26.

Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial.

Schrier RW, Estacio RO, Mehler PS, Hiatt WR.

Nat Clin Pract Nephrol. 2007 Aug;3(8):428-38. Review.

PMID:
17653121
27.

Comprehensive coronary artery disease care in a safety-net hospital: results of Get With The Guidelines quality improvement initiative.

Krantz MJ, Baker WA, Estacio RO, Haynes DK, Mehler PS, Fonarow GC, Long CS.

J Manag Care Pharm. 2007 May;13(4):319-25.

28.
29.

Exercise capacity is a predictor of cardiovascular events in patients with type 2 diabetes mellitus.

Seyoum B, Estacio RO, Berhanu P, Schrier RW.

Diab Vasc Dis Res. 2006 Dec;3(3):197-201.

PMID:
17160916
30.

Reduction in the incidence of acute myocardial infarction associated with a citywide smoking ordinance.

Bartecchi C, Alsever RN, Nevin-Woods C, Thomas WM, Estacio RO, Bartelson BB, Krantz MJ.

Circulation. 2006 Oct 3;114(14):1490-6. Epub 2006 Sep 25.

PMID:
17000911
31.

Impaired fibrinolytic activity in type II diabetes: correlation with urinary albumin excretion and progression of renal disease.

Kamgar M, Nobakhthaghighi N, Shamshirsaz AA, Estacio RO, McFann KK, Schrier RW.

Kidney Int. 2006 May;69(10):1899-903.

32.

Bridging the quality gap in diabetic hyperlipidemia: a practice-based intervention.

Mehler PS, Krantz MJ, Lundgren RA, Estacio RO, MacKenzie TD, Petralia L, Hiatt WR.

Am J Med. 2005 Dec;118(12):1414.

PMID:
16378790
33.

Angiotensin-converting enzyme inhibitors and myocardial infarction: a class effect?

Krantz MJ, Estacio RO, Mehler PS.

Am J Cardiol. 2005 Apr 1;95(7):924. No abstract available.

PMID:
15781039
34.

Rapid microalbuminuria screening in type 2 diabetes mellitus: simplified approach with Micral test strips and specific gravity.

Parikh CR, Fischer MJ, Estacio R, Schrier RW.

Nephrol Dial Transplant. 2004 Jul;19(7):1881-5. Epub 2004 May 25. Erratum in: Nephrol Dial Transplant. 2004 Sep;19(9):2425.

PMID:
15161951
35.

Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes.

Hockensmith ML, Estacio RO, Mehler P, Havranek EP, Ecder ST, Lundgren RA, Schrier RW.

J Card Fail. 2004 Apr;10(2):126-31.

PMID:
15101024
36.

Diabetic autonomic neuropathy is associated with an increased incidence of strokes.

Cohen JA, Estacio RO, Lundgren RA, Esler AL, Schrier RW.

Auton Neurosci. 2003 Oct 31;108(1-2):73-8.

PMID:
14614967
37.

Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial.

Havranek EP, Esler A, Estacio RO, Mehler PS, Schrier RW; Appropriate Blood Pressure Control in Diabetes Trial.

Am Heart J. 2003 Jun;145(6):993-8.

PMID:
12796754
38.

Lack of improvement in the treatment of hyperlipidemia among patients with type 2 diabetes.

Mehler PS, Esler A, Estacio RO, MacKenzie TD, Hiatt WR, Schrier RW.

Am J Med. 2003 Apr 1;114(5):377-82.

PMID:
12714127
39.

Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes.

Mehler PS, Coll JR, Estacio R, Esler A, Schrier RW, Hiatt WR.

Circulation. 2003 Feb 11;107(5):753-6.

PMID:
12578880
40.

Treatment of high-risk diabetic patients with angiotensin II receptor blockers.

Estacio R.

Diabetes Obes Metab. 2001 Dec;3(6):472-6. Review.

PMID:
11903421
41.
43.

Smoking and abnormalities in renal function.

Mehler PS, Estacio R.

Ann Intern Med. 2001 Jul 3;135(1):67. No abstract available.

PMID:
11434751
44.

Additional follow-up from the ABCD trial in patients with type 2 diabetes and hypertension.

Schrier RW, Estacio RO.

N Engl J Med. 2000 Dec 28;343(26):1969. No abstract available.

PMID:
11186674
45.

Diabetic nephropathy: pathogenesis, diagnosis, and prevention of progression.

Estacio RO, Schrier RW.

Adv Intern Med. 2001;46:359-408. Review. No abstract available.

PMID:
11147259
46.

Pharmacodynamics and intubating conditions of cisatracurium in children during halothane and opioid anesthesia.

Kenaan CA, Estacio RL, Bikhazi GB.

J Clin Anesth. 2000 May;12(3):173-6.

PMID:
10869913
47.

Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

Estacio RO, Jeffers BW, Gifford N, Schrier RW.

Diabetes Care. 2000 Apr;23 Suppl 2:B54-64.

PMID:
10860192
48.

Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus.

Stabler SP, Estacio R, Jeffers BW, Cohen JA, Allen RH, Schrier RW.

Metabolism. 1999 Sep;48(9):1096-101.

PMID:
10484047
49.

Deletion polymorphism of the angiotensin converting enzyme gene is associated with an increase in left ventricular mass in men with type 2 diabetes mellitus.

Estacio RO, Jeffers BW, Havranek EP, Krick D, Raynolds M, Schrier RW.

Am J Hypertens. 1999 Jun;12(6):637-42.

PMID:
10371375
50.

Supplemental Content

Loading ...
Support Center